MedTrace Logo

Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism

NCT04932135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-10-31

No results posted yet for this study

Summary

The investigators want to investigate if a continuous heart rate monitoring with a wrist worn fitnesstracker can be useful in the treatment and surveillance of patients suffering from Graves' disease.The aim of our research project is two-fold: First, to evaluate the use of continuous heart rate monitoring as a potential substitute for hormone measurements during treatment of hyperthyroidism. Second, to use continuous heart rate monitoring as a tool for early detection of relapse after discontinuation of antithyroid drugs.

Conditions

  • Hyperthyroidism
  • Graves Disease

Interventions

DIAGNOSTIC_TEST

Continuous heart rate monitoring

Continuous heart rate monitoring with a wrist worn fitnesstracker

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2023-03-21
Completion
2023-10-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932135 on ClinicalTrials.gov